A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.

Conditions:   Alpha 1-Antitrypsin Deficiency;   Emphysema;   COPD Interventions:   Drug: Placebo Oral Tablet;   Drug: Alvelestat oral tablet - dose 1;   Drug: Alvelestat oral tablet - dose 2 Sponsors:   Mereo BioPharma;   Syneos Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials